Venus Remedies Limited — Important, 10-02-2025: Updates

Venus Remedies has received marketing authorization for its injectable product Enoxaparin in Indonesia, covering all major strengths. This approval significantly bolsters the company's presence in the Indonesian market and aligns with its broader expansion strategy in Southeast Asia. The development is expected to enhance market reach and potentially drive revenue growth for Venus Remedies, providing a positive outlook for future operations in the region. Investors should monitor the company's progress in capitalizing on this opportunity and its impact on financial performance.